Introduction
Sugammadex is an efficient reversal agent at any time, after neuromuscular blockade. It provides complete reversal for light or deep block facilitating rapid airway control and decreases anesthesia recovery period in outpatient surgeries in children.
Patient and methods
After ethical committee approval, informed consent and sample size calculation, 70 patients planned for outpatient total bilateral tonsillectomy were divided randomly into 2 groups. Group S ( = 35) received 2 mg/kg sugammadex to reversing NMB achieved by rocuronium. Group N ( = 35) received 0.05 mg/kg neostigmine and atropine sulfate 0.01 mg/kg, and extubation time (time from administration of reversal agent to time of extubation), train-of-four ratio, time to reach train-of-four >0.9, and side effects were recorded.
Results
There was no significant difference in demographic variables. TOF ratio after reversing was a statistically less in group S than in group N ( < 0.05). The time when TOF rate exceeded 0.9 and extubation time were less in group S than in group N with significant difference ( < 0.05). No adverse effect was recorded in both groups.
Conclusions
Sugammadex has created a novel rapid, effective and reliable retrieval from NMB with rocuronium in children undergoing tonsillectomy with no side effects.